Exagen Inc. Common Stock (XGN) is a publicly traded Healthcare sector company. As of May 21, 2026, XGN trades at $3.83 with a market cap of $84.32M and a P/E ratio of -4.24. XGN moved +2.95% today. Year to date, XGN is -35.63%; over the trailing twelve months it is -35.74%. Its 52-week range spans $2.38 to $12.23. Analyst consensus is strong buy with an average price target of $8.67. Rallies surfaces XGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes XGN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $3.83 |
| Market Cap | $84.32M |
| P/E Ratio | -4.24 |
| EPS | $-0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.23 |
| 52-Week Low | $2.38 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $68.38M |
| Net Income | $-20.17M |
| Gross Margin | 58.32% |
7 analysts cover XGN: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.67.